INTERNATIONAL PATENT: SHANGHAI MAAGI MEDICAL TECHNOLOGY CO., LTD, 上海美杰医疗科技有限公司 FILES APPLICATION FOR "METHOD FOR INDUCING PERIPHERAL BLOOD CX3CR1+ POTENTIALLY TUMOR-REACTIVE T CELLS"

GENEVA, May 9 -- SHANGHAI MAAGI MEDICAL TECHNOLOGY CO., LTD (Room 403 & 405, Floor 4, No.418, Guiping RoadXuhui District, Shanghai 200240), 上海美杰医疗科技有限公司 (中国上海市徐汇区桂平路418号4层403、405室) filed a patent application (PCT/CN2024/129029) for "METHOD FOR INDUCING PERIPHERAL BLOOD CX3CR1+ POTENTIALLY TUMOR-REACTIVE T CELLS" on Oct 31, 2024. With publication no. WO/2026/091010, the details related to the patent application was published on May 07, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is ...